On Friday, Merck announced positive results on its patent infringement case against Viatris, while Amgen faces political headwinds from the White House.
https://www.pharmalive.com/wp-content/uploads/2021/10/Merck-COVID-19-Antiviral-Cuts-Death-Hospitalizations-in-Half-BioSpace-10-1-21.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-09-23 10:51:062022-09-23 10:51:06Patent Proceedings: Merck’s Favorable Result and Amgen’s Supreme Court Case
